Final Report Summary - MICAT (MEDICAL IMAGE ANALYSIS FOR CANCER TREATMENT MONITORING AND TUMOR ATLAS FORMATION)
A new segmentation tool for extracting surfaces of 3D tumor volumes from brain MRI was developed based on the cellular-automata framework, starting with a single line on a 2D MR plane, which followed the radiological practice of tumor maximum diameter evaluation. The algorithm delineates the gross tumor volume and necrotic regions of the brain tumors on contrast enhanced T1-weighted MRI. It was also extended to multimodal tumor segmentation in order to delineate the edema regions and non-enhancing content of the tumor tissue over T1, T2, and FLAIR image volumes. The algorithm was among top 3 of the state-of-the-art algorithms in the Live Challenge on Multimodal BRain Tumor Segmentation (BRaTS) at MICCAI 2012.
New algorithms for alignment of brain tumor volumes at baseline and follow-up MRI were developed. First, a rigid registration method based on automatically extracted anatomical landmarks was designed. Next, a deformable registration was utilized to map the follow-up volume onto the coordinate space of the baseline volume. The latter facilitated exploration of new local tumor response criteria. In addition to computation of global measures of tumor response that are based on tumor volume by World Health Organization (WHO), and tumor maximum in plane diameter by Response Evaluation Criteria in Solid Tumors (RECIST), we proposed measures, based on continuum mechanics, of Lagrange strain tensor invariants computed from deformation field between the baseline and follow-up tumor volumes. In a preliminary study, these local measures correlated well with the clinical findings of the disease progression, stability or regression. The constructed graphical user interface with the tools from the MICAT project, has the potential to be further developed into a sophisticated software platform for increased efficiency in quantitative and qualitative analysis of brain tumors in both stages of radio-surgery planning and tumor response follow-up.
Website: http://vpa.sabanciuniv.edu/phpBB2/vpa_views.php?s=4&serial=39